SLC5A2 and type 1 diabetes mellitus: Because SGLT2 inhibitors have a different mechanism of action to other glucose-lowering agents, they can be used in combination with other agents including insulin and can often reduce the amount of insulin required in type 2 and type 1 diabetes [13, 14].